Testing magnesium doses for fast heart rate in atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have atrial fibrillation with a fast heart rate (at least 120 beats per minute).
- You are taking diltiazem to control your heart rate.
- You speak English.
- You do not have serious conditions like very low blood pressure, kidney failure, or a recent heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding magnesium to metoprolol (a heart rate medication) helps slow down a dangerously fast heartbeat caused by atrial fibrillation or flutter. If you have this condition and your heart is beating very fast, this study may help you and future patients manage it more effectively.
This trial tests two different medicines to slow a rapid heartbeat caused by atrial fibrillation or flutter. You will receive either an oral pill (bisoprolol) or intravenous (IV) medication (diltiazem) to see which works better and faster.
This trial tests a medication called etripamil to see if it can quickly slow down a rapid heart rate during episodes of atrial fibrillation. It may help people who have frequent, long-lasting episodes with a fast heartbeat.
This study uses a special heart scan (MCG) to check how well the medication dofetilide is working for people with atrial fibrillation and Long QT syndrome. It is designed for patients who are already in the hospital for treatment.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.